CureVac Welcomes Thaminda Ramanayake as New Chief Business Officer
CureVac has announced the appointment of Thaminda Ramanayake as the new Chief Business Officer.
MRNA | 25/04/2024 | By Aishwarya | 431
Sanofi's Full Embrace of AI and Data Science to Accelerate Medical Breakthroughs for Patients
Sanofi “all in” on artificial intelligence and data science to speed breakthroughs for patients
MRNA | 15/06/2023 | By Sudeep Soparkar | 435
Shanghai-based Everest Medicines commences operations at its mRNA vaccine manufacturing facility
The first phase of the project, covering an area of 58,000 square meters and with an investment of more than RMB 900 million, has a set of advanced production facilities built to meet global and China GMP standards
<br />
MRNA | 28/12/2022 | By Sudeep Soparkar | 392
BioNTech 2nd phase of Covid 19 trials completed
The vaccine, based on messenger RNA (mRNA) technology, is one of the most widely used worldwide against COVID, but has yet to receive an approval in China, which has relied only on domestically-developed vaccine
MRNA | 12/05/2022 | By Sudeep Soparkar | 354
Global diseases treatment with mRNA to be researched by Moderna and IAVI together
Moderna and IAVI, a nonprofit scientific research organization, are teaming up to use mRNA to develop new therapies for a range of diseases like HIV / AIDS, Tuberculosis, anti-microbial-resistant enteric infection and COVID-19.
MRNA | 12/04/2022 | By Sudeep Soparkar | 401
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy